您当前的位置:
技术服务
发布日期:2024/6/27 16:20:00

Title:In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation

标题:在血管平滑肌细胞中,帕里卡托尔能防止磷酸盐诱导的Wnt/β-连环蛋白激活

Authors: Martinez-Moreno JM, Munoz-Castaneda JR, Herencia C, et al.

Journal: American Journal of Physiology - Renal Physiology, 2012

DOI: 10.1152/ajprenal.00262.2012

Abstract

This study investigates the effects of paricalcitol, a vitamin D analog, on vascular smooth muscle cells (VSMCs) in the context of phosphate-induced activation of the Wnt/β-catenin signaling pathway, which is a critical factor in vascular calcification. The researchers found that paricalcitol can inhibit phosphate-induced activation of this pathway, thus potentially preventing vascular calcification.

摘要

本研究旨在探讨维生素D类似物帕立骨化醇(paricalcitol)对血管平滑肌细胞(VSMCs)中磷酸盐诱导的Wnt/β-连环蛋白信号通路激活的抑制作用。研究发现,磷酸盐会诱导Wnt/β-连环蛋白信号通路的激活,导致VSMCs的钙化。帕立骨化醇能够有效地阻止这种激活,从而可能预防血管钙化。

Key Findings

1. **Phosphate-Induced Activation**: Phosphate was shown to induce the Wnt/β-catenin pathway in VSMCs, leading to vascular calcification.

2. **Role of Paricalcitol**: Paricalcitol effectively prevented the activation of the Wnt/β-catenin pathway in these cells.

3. **Mechanism of Action**: The study suggests that paricalcitol's inhibition of this pathway is a potential mechanism for its protective effects against vascular calcification.

主要发现

1. **磷酸盐诱导的激活**: 磷酸盐在血管平滑肌细胞中诱导了Wnt/β-连环蛋白信号通路的激活,这与血管钙化相关。

2. **帕立骨化醇的作用**: 帕立骨化醇有效地抑制了磷酸盐诱导的Wnt/β-连环蛋白信号通路的激活。

3. **作用机制**: 帕立骨化醇通过抑制Wnt/β-连环蛋白信号通路,展示了其预防血管钙化的潜力。

Antifungal Compounds and CAS Numbers

1. **Paricalcitol (帕立骨化醇)**
   - CAS Number: 131918-61-1

2. **Phosphate (磷酸盐)**
   - Various forms such as disodium phosphate (CAS Number: 14265-44-2)

Study Content

**Research Background**: High phosphate levels are common in patients with chronic kidney disease and are closely related to vascular calcification.

**Research Objective**: To explore the role of paricalcitol in preventing phosphate-induced calcification of VSMCs.

**Methods**: Experiments were conducted using cultured VSMCs, and the activation of the Wnt/β-catenin signaling pathway was assessed to evaluate the effect of paricalcitol.

**Results**: Paricalcitol significantly inhibited the phosphate-induced activation of the Wnt/β-catenin signaling pathway.

研究内容

**研究背景**: 高磷酸盐水平在慢性肾病患者中常见,并与血管钙化密切相关。

**研究目标**: 探讨帕立骨化醇在防止磷酸盐诱导的VSMCs钙化中的作用。

**方法**: 使用体外培养的VSMCs进行实验,通过检测Wnt/β-连环蛋白信号通路的激活情况来评估帕立骨化醇的效果。

**结果**: 帕立骨化醇显著抑制了磷酸盐诱导的Wnt/β-连环蛋白信号通路的激活。

相关产品

phosphate 14265-44-2
|50mg
Paricalcitol. 131918-61-1
|5mg
上一篇:维生素D受体激动剂帕里卡托尔预防压力超载小鼠模型中的纤维化和舒张功能障碍 下一篇:引起指甲感染的非皮肤癣菌、非青霉菌丝状真菌的多样性:准确鉴定和抗真菌敏感性测试